Related references
Note: Only part of the references are listed.Gaps between Knowledge and Malaria Treatment Practices after Intensive Anti-Malaria Campaigns in Western Kenya: 2004-2016
Guofa Zhou et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Plasmodium falciparum K13 expression associated with parasite clearance during artemisinin-based combination therapy
M. Silva et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania
Deus S. Ishengoma et al.
MALARIA JOURNAL (2019)
Malaria smear positivity among Kenyan children peaks at intermediate temperatures as predicted by ecological models
Melisa M. Shah et al.
PARASITES & VECTORS (2019)
Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether-lumefantrine or dihydroartemisinin-piperaquine treatment
Protus Omondi et al.
MALARIA JOURNAL (2019)
Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015
Dragan Ljolje et al.
MALARIA JOURNAL (2018)
High efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania
Celine I. Mandara et al.
MALARIA JOURNAL (2018)
Introduction of F446I mutation in the K13 propeller gene leads to increased ring survival rates in Plasmodium falciparum isolates
Jing Wang et al.
MALARIA JOURNAL (2018)
Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial
Pauline Byakika-Kibwika et al.
MALARIA JOURNAL (2018)
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
Mwaka A. Kakolwa et al.
MALARIA JOURNAL (2018)
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea
Livingstone Tavul et al.
MALARIA JOURNAL (2018)
Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination
Manel Ouji et al.
PARASITE (2018)
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015
Mateusz M. Plucinski et al.
MALARIA JOURNAL (2017)
Antimalarial Drug Resistance: A Threat to Malaria Elimination
Didier Menard et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia
Michael Teklemariam et al.
PLOS ONE (2017)
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread
Charles J. Woodrow et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies
M. Isabel Veiga et al.
NATURE COMMUNICATIONS (2016)
Tools and Strategies for Malaria Control and Elimination: What Do We Need to Achieve a Grand Convergence in Malaria?
Janet Hemingway et al.
PLOS BIOLOGY (2016)
Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study
Desalegn Nega et al.
PLOS ONE (2016)
Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network
Liwang Cu et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2015)
The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine
Abdoulaye A. Djimde et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Efficacy of artemether-lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia
Seleshi Kebede Mekonnen et al.
MALARIA JOURNAL (2015)
Chloroquine sensitivity: diminished prevalence of chloroquine-resistant gene marker pfcrt-76 13 years after cessation of chloroquine use in Msambweni, Kenya
William Chege Kiarie et al.
MALARIA JOURNAL (2015)
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Judith Straimer et al.
SCIENCE (2015)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system
Mehdi Ghorbal et al.
NATURE BIOTECHNOLOGY (2014)
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2013)
Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania
Anna Farnert et al.
MALARIA JOURNAL (2012)
Applied Genomics: Data Mining Reveals Species-Specific Malaria Diagnostic Targets More Sensitive than 18S rRNA
Allison Demas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Impact of national malaria control scale-up programmes in Africa: magnitude and attribution of effects
Richard W. Steketee et al.
MALARIA JOURNAL (2010)
Chloroquine resistance before and after its withdrawal in Kenya
Leah Mwai et al.
MALARIA JOURNAL (2009)
Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin
Amar Bir Singh Sidhu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum:: Genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites
AM Nzila et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
